Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb trial of anastrozole + levonorgestrel intravaginal ring for symptomatic endometriosis
NL-OMON42171Phase 2Active, not recruiting
- Sponsor
- Bayer
- Start
- Jan 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of anastrozole, avatrombopag and leuprolide in endometriosis (6 arms), sponsored by Bayer. Primary endpoint: Primary efficacy endpoint. Started Jan 2015; status: active, not recruiting.
02
Drugs
anastrozoleavatrombopagleuprolide
03
Conditions
endometriosis
Beyond the preview
Go deeper on NL-OMON42171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42171.